The New York Times reports that a new vaccine appears to reduce the risk of AIDS infection. This is a novel and important development because this represents the first time in 20 years of vaccine research that an AIDS vaccine shows promise. The vaccine, named RV-144, combines 2 previously unsuccessful genetically engineered vaccines. Thailand researchers conducted a 6-year clinical trial with more than 16,000 men and women volunteers ages 18 to 30. Participants who received the vaccine were 33% less likely to contract the deadly disease.
The NY Times conducted an interview with Dr. Anthony S. Fauci, the director of the National Institute of Allergy and Infectious Diseases, who states that, “For more than 20 years now, vaccine trials have essentially been failures. Now it’s like we were groping down an unlit path, and a door has been opened. We can start asking some very important questions.” Mitchell Warren, the executive director of the AIDS Vaccine Advocacy Coalition, or AVAC, further commented that, “We often talk about whether a vaccine is even possible. This is not the vaccine that ends the epidemic and says, ‘O.K., let’s move on to something else.’ But it’s a fabulous new step that takes us in a new direction.”
Visit The NY Times, “For First Time, AIDS Vaccine Shows Some Success”